X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs IPCA LABS - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD IPCA LABS ORCHID PHARMA LTD/
IPCA LABS
 
P/E (TTM) x -0.8 27.5 - View Chart
P/BV x 0.5 2.1 25.8% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 ORCHID PHARMA LTD   IPCA LABS
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
IPCA LABS
Mar-17
ORCHID PHARMA LTD/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs194643 30.2%   
Low Rs35503 7.0%   
Sales per share (Unadj.) Rs276.5254.4 108.7%  
Earnings per share (Unadj.) Rs-79.216.1 -492.9%  
Cash flow per share (Unadj.) Rs-43.529.8 -145.9%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs53.9194.6 27.7%  
Shares outstanding (eoy) m70.45126.20 55.8%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.42.3 18.4%   
Avg P/E ratio x-1.435.7 -4.1%  
P/CF ratio (eoy) x-2.619.2 -13.7%  
Price / Book Value ratio x2.12.9 72.1%  
Dividend payout %06.2 0.0%   
Avg Mkt Cap Rs m8,06772,300 11.2%   
No. of employees `0002.813.3 21.0%   
Total wages/salary Rs m2,5276,960 36.3%   
Avg. sales/employee Rs Th6,956.12,413.5 288.2%   
Avg. wages/employee Rs Th902.5523.2 172.5%   
Avg. net profit/employee Rs Th-1,993.0152.4 -1,307.3%   
INCOME DATA
Net Sales Rs m19,47732,106 60.7%  
Other income Rs m407226 180.4%   
Total revenues Rs m19,88432,332 61.5%   
Gross profit Rs m1,1034,448 24.8%  
Depreciation Rs m2,5191,730 145.7%   
Interest Rs m5,227241 2,170.6%   
Profit before tax Rs m-6,2362,703 -230.7%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125675 -18.5%   
Profit after tax Rs m-5,5802,028 -275.2%  
Gross profit margin %5.713.9 40.9%  
Effective tax rate %2.025.0 8.0%   
Net profit margin %-28.76.3 -453.6%  
BALANCE SHEET DATA
Current assets Rs m11,01417,340 63.5%   
Current liabilities Rs m32,0609,559 335.4%   
Net working cap to sales %-108.124.2 -445.9%  
Current ratio x0.31.8 18.9%  
Inventory Days Days95100 94.6%  
Debtors Days Days3457 59.0%  
Net fixed assets Rs m29,44020,779 141.7%   
Share capital Rs m705252 279.1%   
"Free" reserves Rs m2,04324,499 8.3%   
Net worth Rs m3,80024,553 15.5%   
Long term debt Rs m9,0183,517 256.4%   
Total assets Rs m46,51039,595 117.5%  
Interest coverage x-0.212.2 -1.6%   
Debt to equity ratio x2.40.1 1,656.6%  
Sales to assets ratio x0.40.8 51.6%   
Return on assets %-0.85.7 -13.3%  
Return on equity %-146.98.3 -1,777.9%  
Return on capital %-3.710.5 -35.6%  
Exports to sales %37.948.6 77.9%   
Imports to sales %22.614.2 158.9%   
Exports (fob) Rs m7,37815,617 47.2%   
Imports (cif) Rs m4,4064,571 96.4%   
Fx inflow Rs m7,51315,617 48.1%   
Fx outflow Rs m5,6495,828 96.9%   
Net fx Rs m1,8659,790 19.0%   
CASH FLOW
From Operations Rs m1,6822,764 60.8%  
From Investments Rs m-9,860-1,432 688.7%  
From Financial Activity Rs m6,644-1,591 -417.5%  
Net Cashflow Rs m-1,535-259 593.1%  

Share Holding

Indian Promoters % 32.3 45.9 70.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 11.4 40.4%  
FIIs % 3.3 25.3 13.0%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 17.4 317.8%  
Shareholders   84,811 36,892 229.9%  
Pledged promoter(s) holding % 54.9 2.1 2,566.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - SANOFI INDIA COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS